{"id":94150,"date":"2026-01-09T15:33:54","date_gmt":"2026-01-09T06:33:54","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/genome-editing-market-mordor\/"},"modified":"2026-10-06T13:44:59","modified_gmt":"2026-10-06T04:44:59","slug":"genome-editing-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/genome-editing-market-mordor\/","title":{"rendered":"\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u306e\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790\uff1a\u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025-2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/genome-editing-market_1653977155544_CL36.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/genome-editing-market-size-image-1749803780826.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \u8abf\u67fb\u306e\u524d\u63d0\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/li>\n<li class=\"toc-level-2\">1.2 \u8abf\u67fb\u7bc4\u56f2<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \u5e02\u5834\u6982\u6cc1<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \u5e02\u5834\u6982\u8981<\/li>\n<li class=\"toc-level-2\">4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\n<ul>\n<li class=\"toc-level-3\">4.2.1 \u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308bCRISPR-Cas\u30b7\u30b9\u30c6\u30e0\u306e\u6025\u901f\u306a\u63a1\u7528<\/li>\n<li class=\"toc-level-3\">4.2.2 \u6c17\u5019\u5909\u52d5\u306b\u5f37\u3044\u4f5c\u7269\u306e\u305f\u3081\u306e\u8fb2\u696d\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u9700\u8981\u306e\u62e1\u5927<\/li>\n<li class=\"toc-level-3\">4.2.3 \u907a\u4f1d\u5b50\u7de8\u96c6\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3078\u306eVC\u304a\u3088\u3073IPO\u8cc7\u91d1\u306e\u6025\u5897<\/li>\n<li class=\"toc-level-3\">4.2.4 \u5e0c\u5c11\u75be\u60a3\u306b\u5bfe\u3059\u308b\u751f\u4f53\u5185\u907a\u4f1d\u5b50\u7de8\u96c6\u6cbb\u7642\u85ac\u306e\u4e3b\u6d41\u5316<\/li>\n<li class=\"toc-level-3\">4.2.5 \u81ea\u52d5\u5316\u304a\u3088\u3073AI\u652f\u63f4\u306b\u3088\u308b\u30cf\u30a4\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0<\/li>\n<li class=\"toc-level-3\">4.2.6 \u65b0\u8208\u56fd\u306b\u304a\u3051\u308b\u653f\u5e9c\u306e\u30d0\u30a4\u30aa\u30a8\u30b3\u30ce\u30df\u30fc\u30ed\u30fc\u30c9\u30de\u30c3\u30d7<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0\n<ul>\n<li class=\"toc-level-3\">4.3.1 \u30d2\u30c8\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u306a\u30aa\u30d5\u30bf\u30fc\u30b2\u30c3\u30c8\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306e\u4e0d\u78ba\u5b9f\u6027<\/li>\n<li class=\"toc-level-3\">4.3.2 GMP\u6e96\u62e0\u306e\u907a\u4f1d\u5b50\u7de8\u96c6\u88fd\u9020\u30b9\u30a4\u30fc\u30c8\u306b\u5bfe\u3059\u308b\u9ad8\u984d\u306a\u8a2d\u5099\u6295\u8cc7<\/li>\n<li class=\"toc-level-3\">4.3.3 \u7de8\u96c6\u3055\u308c\u305f\u7a2e\u5b50\u306b\u5bfe\u3059\u308b\u56fd\u5883\u3092\u8d8a\u3048\u305f\u898f\u5236\u306e\u65ad\u7247\u5316<\/li>\n<li class=\"toc-level-3\">4.3.4 \u9ad8\u5ea6\u306a\u5206\u5b50\u751f\u7269\u5b66\u30b9\u30ad\u30eb\u30bb\u30c3\u30c8\u306b\u304a\u3051\u308b\u4eba\u6750\u4e0d\u8db3<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790\n<ul>\n<li class=\"toc-level-3\">4.4.1 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/li>\n<li class=\"toc-level-3\">4.4.2 \u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b<\/li>\n<li class=\"toc-level-3\">4.4.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/li>\n<li class=\"toc-level-3\">4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/li>\n<li class=\"toc-level-3\">4.4.5 \u7af6\u4e89\u4e0a\u306e\u5bfe\u6297\u95a2\u4fc2<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\uff08\u7c73\u30c9\u30eb\u5efa\u3066\uff09<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5225\n<ul>\n<li class=\"toc-level-3\">5.1.1 \u30af\u30e9\u30b9\u30bf\u30fc\u5316\u3055\u308c\u305f\u898f\u5247\u7684\u9593\u9694\u306e\u77ed\u3044\u56de\u6587\u30ea\u30d4\u30fc\u30c8 (CRISPR)<\/li>\n<li class=\"toc-level-3\">5.1.1 \u8ee2\u5199\u6d3b\u6027\u5316\u56e0\u5b50\u69d8\u30a8\u30d5\u30a7\u30af\u30bf\u30fc\u30cc\u30af\u30ec\u30a2\u30fc\u30bc (TALEN)<\/li>\n<li class=\"toc-level-3\">5.1.3 \u30b8\u30f3\u30af\u30d5\u30a3\u30f3\u30ac\u30fc\u30cc\u30af\u30ec\u30a2\u30fc\u30bc (ZFN)<\/li>\n<li class=\"toc-level-3\">5.1.4 \u30e1\u30ac\u30cc\u30af\u30ec\u30a2\u30fc\u30bc<\/li>\n<li class=\"toc-level-3\">5.1.5 \u30aa\u30ea\u30b4\u30cc\u30af\u30ec\u30aa\u30c1\u30c9\u6307\u5411\u6027\u5909\u7570\u5c0e\u5165 (ODM)<\/li>\n<li class=\"toc-level-3\">5.1.6 \u305d\u306e\u4ed6\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \u5c0e\u5165\u65b9\u6cd5\u5225\n<ul>\n<li class=\"toc-level-3\">5.2.1 \u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc<\/li>\n<li class=\"toc-level-3\">5.2.2 \u975e\u30a6\u30a4\u30eb\u30b9\u7269\u7406\u7684\u65b9\u6cd5<\/li>\n<li class=\"toc-level-3\">5.2.3 \u975e\u30a6\u30a4\u30eb\u30b9\u5316\u5b66\u7684\u65b9\u6cd5<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \u7528\u9014\u5225\n<ul>\n<li class=\"toc-level-3\">5.3.1 \u7d30\u80de\u682a\u5de5\u5b66<\/li>\n<li class=\"toc-level-3\">5.3.2 \u907a\u4f1d\u5b50&amp;\u7d30\u80de\u6cbb\u7642<\/li>\n<li class=\"toc-level-3\">5.3.3 \u5275\u85ac&amp;\u6a5f\u80fd\u30b2\u30ce\u30df\u30af\u30b9<\/li>\n<li class=\"toc-level-3\">5.3.4 \u8fb2\u696d\u4f5c\u7269\u5de5\u5b66<\/li>\n<li class=\"toc-level-3\">5.3.5 \u8a3a\u65ad&amp;\u5408\u6210\u751f\u7269\u5b66<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225\n<ul>\n<li class=\"toc-level-3\">5.4.1 \u88fd\u85ac&amp;\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d<\/li>\n<li class=\"toc-level-3\">5.4.2 \u5b66\u8853&amp;\u653f\u5e9c\u7814\u7a76\u6a5f\u95a2<\/li>\n<li class=\"toc-level-3\">5.4.3 \u53d7\u8a17\u7814\u7a76\u6a5f\u95a2<\/li>\n<li class=\"toc-level-3\">5.4.4 \u8fb2\u696d&amp;\u98df\u54c1\u4f01\u696d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \u5730\u57df\u5225\n<ul>\n<li class=\"toc-level-3\">5.5.1 \u5317\u7c73<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \u7c73\u56fd<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \u30ab\u30ca\u30c0<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \u30e1\u30ad\u30b7\u30b3<\/li>\n<li class=\"toc-level-3\">5.5.2 \u6b27\u5dde<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \u30c9\u30a4\u30c4<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \u82f1\u56fd<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \u30d5\u30e9\u30f3\u30b9<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \u30a4\u30bf\u30ea\u30a2<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \u30b9\u30da\u30a4\u30f3<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/li>\n<li class=\"toc-level-3\">5.5.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \u4e2d\u56fd<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \u65e5\u672c<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \u30a4\u30f3\u30c9<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \u97d3\u56fd<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/li>\n<li class=\"toc-level-3\">5.5.4 \u4e2d\u6771&amp;\u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771&amp;\u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-3\">5.5.5 \u5357\u7c73<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \u30d6\u30e9\u30b8\u30eb<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \u5e02\u5834\u96c6\u4e2d\u5ea6<\/li>\n<li class=\"toc-level-2\">6.2 \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790<\/li>\n<li class=\"toc-level-2\">6.3 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\uff08\u30b0\u30ed\u30fc\u30d0\u30eb\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u5e02\u5834\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u5229\u7528\u53ef\u80fd\u306a\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u60c5\u5831\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u30e9\u30f3\u30ad\u30f3\u30b0\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1&amp;\u30b5\u30fc\u30d3\u30b9\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u3092\u542b\u3080\uff09\n<ul>\n<li class=\"toc-level-3\">6.3.1 Thermo Fisher Scientific Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 Merck KGaA (Sigma-Aldrich)<\/li>\n<li class=\"toc-level-3\">6.3.3 CRISPR Therapeutics AG<\/li>\n<li class=\"toc-level-3\">6.3.4 Editas Medicine Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 Horizon Discovery Group plc<\/li>\n<li class=\"toc-level-3\">6.3.6 Intellia Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.7 Beam Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.8 Sangamo Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.9 GenScript Biotech Corporation<\/li>\n<li class=\"toc-level-3\">6.3.10 Synthego Corporation<\/li>\n<li class=\"toc-level-3\">6.3.11 Takara Bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.12 Integrated DNA Technologies Inc.<\/li>\n<li class=\"toc-level-3\">6.3.13 Lonza Group AG<\/li>\n<li class=\"toc-level-3\">6.3.14 New England Biolabs Inc.<\/li>\n<li class=\"toc-level-3\">6.3.15 OriGene Technologies Inc.<\/li>\n<li class=\"toc-level-3\">6.3.16 Caribou Biosciences Inc.<\/li>\n<li class=\"toc-level-3\">6.3.17 Bluebird Bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 Bio-Rad Laboratories Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 Agilent Technologies Inc.<\/li>\n<li class=\"toc-level-3\">6.3.20 QIAGEN N.V.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \u5e02\u5834\u6a5f\u4f1a&amp;\u5c06\u6765\u5c55\u671b<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u306e\u6982\u8981<\/p>\n<p>\u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c<\/p>\n<p>\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f106\u5104\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012030\u5e74\u307e\u3067\u306b226.2\u5104\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b\u304a\u3051\u308b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f16.36%\u3067\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5e02\u5834\u3067\u3042\u308a\u3001\u5317\u7c73\u304c\u6700\u5927\u306e\u5e02\u5834\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u96c6\u4e2d\u5ea6\u306f\u4e2d\u7a0b\u5ea6\u3067\u3059\u3002<\/p>\n<p>\u5e02\u5834\u5206\u6790<\/p>\n<p>CRISPR-Cas9\u306e\u81e8\u5e8a\u7684\u691c\u8a3c\u3001\u6c17\u5019\u5909\u52d5\u306b\u5f37\u3044\u4f5c\u7269\u306e\u9700\u8981\u5897\u52a0\u3001\u8c4a\u5bcc\u306a\u30d9\u30f3\u30c1\u30e3\u30fc\u30ad\u30e3\u30d4\u30bf\u30eb\uff08VC\uff09\u8cc7\u91d1\u304c\u3001\u30b2\u30ce\u30e0\u7de8\u96c6\u6280\u8853\u306e\u5546\u696d\u7684\u63a1\u7528\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002CRISPR\u6cbb\u7642\u6cd5\u306b\u5bfe\u3059\u308b\u898f\u5236\u5f53\u5c40\u306e\u4fe1\u983c\u3082\u9ad8\u307e\u3063\u3066\u304a\u308a\u3001\u591a\u304f\u306e\u56fd\u3067\u907a\u4f1d\u5b50\u7de8\u96c6\u4f5c\u7269\u304c\u5f93\u6765\u306e\u80b2\u7a2e\u4f5c\u7269\u3068\u540c\u69d8\u306b\u6271\u308f\u308c\u308b\u3088\u3046\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u6226\u7565\u3068\u3057\u3066\u306f\u3001GMP\uff08\u9069\u6b63\u88fd\u9020\u898f\u7bc4\uff09\u306b\u6e96\u62e0\u3057\u305f\u751f\u7523\u80fd\u529b\u306e\u62e1\u5927\u3001\u30cc\u30af\u30ec\u30a2\u30fc\u30bc\u8a2d\u8a08\u3078\u306eAI\u7d71\u5408\u3001\u77e5\u7684\u8ca1\u7523\u4e0a\u306e\u512a\u4f4d\u6027\u3092\u78ba\u4fdd\u3059\u308b\u305f\u3081\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u306e\u7de0\u7d50\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u5927\u624b\u88fd\u85ac\u4f1a\u793e\u3068\u6a5f\u654f\u306a\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u4f01\u696d\u3068\u306e\u9023\u643a\u304c\u5f37\u5316\u3055\u308c\u3001\u6cbb\u7642\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u304c\u62e1\u5927\u3057\u3001\u5e02\u5834\u6295\u5165\u307e\u3067\u306e\u6642\u9593\u304c\u77ed\u7e2e\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u88fd\u9020\u898f\u6a21\u306e\u62e1\u5927\u3001\u8cbf\u6613\u653f\u7b56\u306e\u4e0d\u4e00\u81f4\u3001\u719f\u7df4\u52b4\u50cd\u8005\u306e\u4e0d\u8db3\u304c\u5e02\u5834\u306e\u898b\u901a\u3057\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u30ec\u30dd\u30fc\u30c8\u306e\u30dd\u30a4\u30f3\u30c8<\/p>\n<p>*   \u6280\u8853\u5225: 2024\u5e74\u306b\u306fCRISPR\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u30b7\u30a7\u30a2\u306e41.62%\u3092\u5360\u3081\u3001TALEN\u306f2030\u5e74\u307e\u3067\u306b19.89%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u9001\u9054\u65b9\u6cd5\u5225: 2024\u5e74\u306b\u306f\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u304c\u53ce\u76ca\u306e46.72%\u3092\u5360\u3081\u3001\u975e\u30a6\u30a4\u30eb\u30b9\u7269\u7406\u7684\u9001\u9054\u306f2030\u5e74\u307e\u3067\u306b16.52%\u306eCAGR\u3067\u62e1\u5927\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u7528\u9014\u5225: 2024\u5e74\u306b\u306f\u907a\u4f1d\u5b50\u30fb\u7d30\u80de\u6cbb\u7642\u304c\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u898f\u6a21\u306e34.45%\u3092\u5360\u3081\u3001\u8a3a\u65ad\u85ac\u304a\u3088\u3073\u5408\u6210\u751f\u7269\u5b66\u306f2025\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u306617.12%\u306e\u6700\u901fCAGR\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225: 2024\u5e74\u306b\u306f\u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u304c\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u306e52.38%\u306e\u30b7\u30a7\u30a2\u3092\u7372\u5f97\u3057\u30012030\u5e74\u307e\u3067\u306b16.99%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5730\u57df\u5225: 2024\u5e74\u306b\u306f\u5317\u7c73\u304c\u53ce\u76ca\u30b7\u30a7\u30a2\u306e41.25%\u3092\u7dad\u6301\u3057\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f\u540c\u671f\u9593\u306b20.23%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e16\u754c\u306e\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf\uff08\u63a8\u9032\u8981\u56e0\uff09<\/p>\n<p>*   \u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308bCRISPR-Cas\u30b7\u30b9\u30c6\u30e0\u306e\u6025\u901f\u306a\u63a1\u7528: FDA\u304c\u521d\u306eCRISPR\u6cbb\u7642\u6cd5\u3092\u627f\u8a8d\u3057\u305f\u3053\u3068\u3067\u3001\u3088\u308a\u5e83\u7bc4\u306a\u81e8\u5e8a\u63a2\u7d22\u304c\u53ef\u80fd\u306b\u306a\u308a\u3001\u958b\u767a\u30b5\u30a4\u30af\u30eb\u304c\u6700\u59272\u5e74\u77ed\u7e2e\u3055\u308c\u307e\u3057\u305f\u3002\u8840\u6db2\u5b66\u3001\u773c\u79d1\u5b66\u3001\u56fa\u5f62\u816b\u760d\u306e\u7814\u7a76\u306b\u304a\u3051\u308b\u80af\u5b9a\u7684\u306a\u7d50\u679c\u306f\u3001\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u591a\u69d8\u6027\u3092\u793a\u3057\u3001\u6301\u7d9a\u7684\u306a\u8cc7\u91d1\u6d41\u5165\u3092\u4fc3\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6c17\u5019\u5909\u52d5\u306b\u5f37\u3044\u4f5c\u7269\u306b\u5bfe\u3059\u308b\u8fb2\u696d\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u9700\u8981\u306e\u62e1\u5927: \u30b2\u30ce\u30e0\u7de8\u96c6\u3055\u308c\u305f\u7c73\u3001\u5e72\u3070\u3064\u8010\u6027\u30c8\u30a6\u30e2\u30ed\u30b3\u30b7\u3001\u8010\u71b1\u6027\u5bb6\u755c\u306a\u3069\u306f\u3001\u53ce\u91cf\u3092\u7dad\u6301\u3057\u306a\u304c\u3089\u6c17\u5019\u5909\u52d5\u306e\u5f71\u97ff\u3092\u7de9\u548c\u3059\u308b\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u4f8b\u3067\u3059\u3002\u5916\u56fdDNA\u304c\u6b8b\u5b58\u3057\u306a\u304416\u306e\u7ba1\u8f44\u533a\u57df\u306b\u304a\u3051\u308b\u898f\u5236\u514d\u9664\u306f\u3001\u5546\u696d\u5316\u3092\u52a0\u901f\u3055\u305b\u3001\u5c0f\u898f\u6a21\u306a\u80b2\u7a2e\u5bb6\u304c\u904e\u9177\u306aGMO\u898f\u5236\u306a\u3057\u306b\u5e02\u5834\u306b\u53c2\u5165\u3059\u308b\u3053\u3068\u3092\u53ef\u80fd\u306b\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u907a\u4f1d\u5b50\u7de8\u96c6\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u4f01\u696d\u3078\u306eVC\u304a\u3088\u3073IPO\u8cc7\u91d1\u306e\u6025\u5897: 2024\u5e74\u306b\u306f\u4e00\u6642\u7684\u306a\u843d\u3061\u8fbc\u307f\u304c\u3042\u3063\u305f\u3082\u306e\u306e\u3001\u9ad8\u54c1\u8cea\u306a\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u4f9d\u7136\u3068\u3057\u3066\u5de8\u984d\u306e\u8cc7\u91d1\u8abf\u9054\u3092\u884c\u3044\u3001\u5927\u624b\u88fd\u85ac\u4f1a\u793e\u306e\u8cc7\u672c\u3068\u6a5f\u654f\u306a\u7814\u7a76\u958b\u767a\u3092\u878d\u5408\u3055\u305b\u308b\u63d0\u643a\u3092\u7d50\u3093\u3067\u3044\u307e\u3059\u3002\u6226\u7565\u7684\u6295\u8cc7\u306f\u3001\u8d85\u5c0f\u578bCRISPR\u9175\u7d20\u3001AI\u30ac\u30a4\u30c9\u8a2d\u8a08\u30b9\u30a4\u30fc\u30c8\u3001\u30d7\u30ed\u30b0\u30e9\u30e0\u53ef\u80fd\u306a\u30a4\u30f3\u30c6\u30b0\u30e9\u30fc\u30bc\u306b\u8cc7\u6e90\u3092\u6295\u5165\u3057\u3001\u6280\u8853\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5e0c\u5c11\u75be\u60a3\u306b\u5bfe\u3059\u308bin vivo\u907a\u4f1d\u5b50\u7de8\u96c6\u6cbb\u7642\u306e\u4e3b\u6d41\u5316: \u5358\u56de\u6295\u4e0e\u306ein vivo\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u6301\u7d9a\u7684\u306a\u30bf\u30f3\u30d1\u30af\u8cea\u30ce\u30c3\u30af\u30c0\u30a6\u30f3\u3092\u5b9f\u73fe\u3057\u3001\u8102\u8cea\u30ca\u30ce\u7c92\u5b50\u30b7\u30b9\u30c6\u30e0\u306f\u809d\u81d3\u4ee5\u5916\u306e\u81d3\u5668\u7279\u7570\u7684\u7de8\u96c6\u3092\u9054\u6210\u3057\u3066\u3044\u307e\u3059\u3002FDA\u306e\u30ac\u30a4\u30c0\u30f3\u30b9\u306f\u5e0c\u5c11\u75be\u60a3\u5019\u88dc\u306e\u8fc5\u901f\u5be9\u67fb\u3092\u512a\u5148\u3057\u3066\u304a\u308a\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u4eca\u5f8c\u6570\u5e74\u3067\u767a\u58f2\u4e88\u5b9a\u306ein vivo\u88fd\u54c1\u3067\u7533\u8acb\u3092\u7a4d\u307f\u91cd\u306d\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u81ea\u52d5\u5316\u304a\u3088\u3073AI\u652f\u63f4\u306e\u30cf\u30a4\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0: \u3053\u308c\u3089\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u30b2\u30ce\u30e0\u7de8\u96c6\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u306e\u52b9\u7387\u3068\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u3092\u5411\u4e0a\u3055\u305b\u3001\u7814\u7a76\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u65b0\u8208\u56fd\u306b\u304a\u3051\u308b\u30d0\u30a4\u30aa\u30a8\u30b3\u30ce\u30df\u30fc\u30ed\u30fc\u30c9\u30de\u30c3\u30d7: \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u5730\u57df\u3067\u306f\u3001\u653f\u5e9c\u306e\u30d0\u30a4\u30aa\u30a8\u30b3\u30ce\u30df\u30fc\u30ed\u30fc\u30c9\u30de\u30c3\u30d7\u304c\u30b2\u30ce\u30e0\u7de8\u96c6\u6280\u8853\u306e\u9577\u671f\u7684\u306a\u6210\u9577\u3092\u652f\u63f4\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6291\u5236\u8981\u56e0<\/p>\n<p>*   \u30d2\u30c8\u306b\u304a\u3051\u308b\u30aa\u30d5\u30bf\u30fc\u30b2\u30c3\u30c8\u52b9\u679c\u306e\u9577\u671f\u7684\u306a\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306e\u4e0d\u78ba\u5b9f\u6027: \u8d85\u6df1\u5c64\u30b7\u30fc\u30b1\u30f3\u30b7\u30f3\u30b0\u306b\u3088\u308a\u6570\u767e\u306e\u6f5c\u5728\u7684\u306a\u30aa\u30d5\u30bf\u30fc\u30b2\u30c3\u30c8\u90e8\u4f4d\u304c\u660e\u3089\u304b\u306b\u306a\u308a\u7d9a\u3051\u3066\u304a\u308a\u3001\u898f\u5236\u5f53\u5c40\u306f\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a13\u306b\u9032\u3080\u524d\u306b\u3001\u3088\u308a\u5e83\u7bc4\u306a\u751f\u4f53\u5185\u5206\u5e03\u304a\u3088\u3073\u8010\u4e45\u6027\u7814\u7a76\u3092\u8981\u6c42\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   GMP\u6e96\u62e0\u306e\u907a\u4f1d\u5b50\u7de8\u96c6\u88fd\u9020\u30b9\u30a4\u30fc\u30c8\u306b\u5bfe\u3059\u308b\u9ad8\u984d\u306a\u8a2d\u5099\u6295\u8cc7: \u65b0\u898f\u30d7\u30e9\u30f3\u30c8\u306b\u306f2\u5104\uff5e5\u5104\u30c9\u30eb\u306e\u8cbb\u7528\u304c\u304b\u304b\u308a\u3001\u5c02\u9580\u7684\u306a\u30af\u30ea\u30fc\u30f3\u30eb\u30fc\u30e0\u8a2d\u8a08\u304c\u5fc5\u8981\u3067\u3059\u3002\u3053\u306e\u8cc7\u672c\u96c6\u7d04\u5ea6\u306f\u3001\u5c0f\u898f\u6a21\u4f01\u696d\u306e\u53c2\u5165\u3092\u5236\u9650\u3057\u3001\u65e2\u5b58\u306e\u30d5\u30c3\u30c8\u30d7\u30ea\u30f3\u30c8\u3092\u6301\u3064CDMO\u3078\u306e\u7d71\u5408\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u7de8\u96c6\u3055\u308c\u305f\u7a2e\u5b50\u306b\u5bfe\u3059\u308b\u56fd\u5883\u3092\u8d8a\u3048\u305f\u898f\u5236\u306e\u65ad\u7247\u5316: \u4e16\u754c\u8cbf\u6613\u306b\u304a\u3044\u3066\u3001\u7279\u306bEU\u3068\u7c73\u56fd\u306e\u898f\u5236\u306e\u76f8\u9055\u304c\u91cd\u8981\u3067\u3042\u308a\u3001\u5546\u696d\u5316\u3092\u9045\u3089\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u9ad8\u5ea6\u306a\u5206\u5b50\u751f\u7269\u5b66\u30b9\u30ad\u30eb\u30bb\u30c3\u30c8\u306b\u304a\u3051\u308b\u4eba\u6750\u4e0d\u8db3: \u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30cf\u30d6\u306b\u96c6\u4e2d\u3057\u3066\u304a\u308a\u3001\u77ed\u671f\u7684\u306a\u5f71\u97ff\u3092\u53ca\u307c\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30bb\u30b0\u30e1\u30f3\u30c8\u5206\u6790<\/p>\n<p>*   \u6280\u8853\u5225: CRISPR\u306f2024\u5e74\u306b41.62%\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u307e\u3057\u305f\u304c\u3001TALEN\u306f19.89%\u306eCAGR\u3067\u6210\u9577\u3057\u3001\u7af6\u4e89\u74b0\u5883\u3092\u518d\u69cb\u7bc9\u3057\u3066\u3044\u307e\u3059\u3002AI\u30c4\u30fc\u30eb\u306f\u30ac\u30a4\u30c9RNA\u306e\u6700\u9069\u5316\u30b5\u30a4\u30af\u30eb\u3092\u5287\u7684\u306b\u77ed\u7e2e\u3057\u3001\u30cc\u30af\u30ec\u30a2\u30fc\u30bc\u8a2d\u8a08\u306e\u53ef\u80fd\u6027\u3092\u5e83\u3052\u3066\u3044\u307e\u3059\u3002\u30d9\u30fc\u30b9\u7de8\u96c6\u3084\u30d7\u30e9\u30a4\u30e0\u7de8\u96c6\u306f\u3001\u5b89\u5168\u6027\u91cd\u8996\u306e\u4ee3\u66ff\u624b\u6bb5\u3068\u3057\u3066\u6ce8\u76ee\u3092\u96c6\u3081\u3001\u7279\u306b\u4e8c\u672c\u9396\u5207\u65ad\u30ea\u30b9\u30af\u306b\u654f\u611f\u306a\u9069\u5fdc\u75c7\u5206\u91ce\u3067\u5c02\u7528\u306e\u30b5\u30d6\u30de\u30fc\u30b1\u30c3\u30c8\u3092\u5f62\u6210\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u30b8\u30f3\u30af\u30d5\u30a3\u30f3\u30ac\u30fc\u30cc\u30af\u30ec\u30a2\u30fc\u30bc\u306f\u3001\u77e5\u7684\u8ca1\u7523\u306e\u81ea\u7531\u304c\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u3088\u308a\u3082\u512a\u5148\u3055\u308c\u308b\u8d85\u7279\u7570\u7684\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u30cb\u30c3\u30c1\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u9001\u9054\u65b9\u6cd5\u5225: \u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u306f\u3001\u4e88\u6e2c\u53ef\u80fd\u306a\u5f62\u8cea\u5c0e\u5165\u52b9\u7387\u3068\u5341\u5206\u306b\u7406\u89e3\u3055\u308c\u305f\u898f\u5236\u7d4c\u8def\u306b\u3088\u308a\u30012024\u5e74\u306e\u53ce\u76ca\u306e46.72%\u3092\u5360\u3081\u3001\u9ad8\u4fa1\u5024\u306eex vivo\u6cbb\u7642\u6cd5\u3067\u9700\u8981\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u96fb\u6c17\u7a7f\u5b54\u6cd5\u3001\u30de\u30a4\u30af\u30ed\u6d41\u4f53\u5727\u5165\u6cd5\u3001\u7d44\u7e54\u9078\u629e\u7684\u8102\u8cea\u30ca\u30ce\u7c92\u5b50\u306a\u3069\u306e\u975e\u30a6\u30a4\u30eb\u30b9\u7269\u7406\u7684\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u3001\u30a6\u30a4\u30eb\u30b9\u30b7\u30b9\u30c6\u30e0\u306b\u56fa\u6709\u306e\u514d\u75ab\u539f\u6027\u3084\u30da\u30a4\u30ed\u30fc\u30c9\u30b5\u30a4\u30ba\u5236\u9650\u3092\u89e3\u6c7a\u3059\u308b\u305f\u3081\u300116.52%\u306eCAGR\u3067\u62e1\u5927\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u7528\u9014\u5225: \u907a\u4f1d\u5b50\u30fb\u7d30\u80de\u6cbb\u7642\u306f2024\u5e74\u306e\u53ce\u76ca\u306e34.45%\u3092\u7dad\u6301\u3057\u3001\u307b\u3068\u3093\u3069\u306e\u77ed\u671f\u7684\u306a\u5546\u696d\u7684\u767a\u58f2\u3092\u652f\u3048\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u8a3a\u65ad\u85ac\u306fCRISPR-Cas13\u30d9\u30fc\u30b9\u306eRNA\u691c\u51fa\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u611f\u67d3\u75c7\u304a\u3088\u3073\u816b\u760d\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u5e02\u5834\u306b\u53c2\u5165\u3059\u308b\u305f\u3081\u300117.12%\u306eCAGR\u3092\u8a18\u9332\u3059\u308b\u3067\u3057\u3087\u3046\u3002\u8fb2\u696d\u4f5c\u7269\u5de5\u5b66\u306f\u3001\u6c17\u5019\u653f\u7b56\u304c\u8010\u6027\u54c1\u7a2e\u3092\u5968\u52b1\u3059\u308b\u305f\u3081\u62e1\u5927\u3092\u7d9a\u3051\u3066\u3044\u307e\u3059\u304c\u3001\u898f\u5236\u306e\u65ad\u7247\u5316\u304c\u56fd\u5883\u3092\u8d8a\u3048\u305f\u8cbf\u6613\u3092\u9045\u3089\u305b\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225: \u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f2024\u5e74\u306e\u9700\u8981\u306e52.38%\u3092\u5360\u3081\u3001\u7cbe\u5bc6\u533b\u7642\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u5897\u52a0\u306b\u4f34\u304416.99%\u306eCAGR\u3067\u62e1\u5927\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30b2\u30ce\u30e0\u7de8\u96c6\u7523\u696d\u306f\u3001\u57fa\u790e\u7684\u306a\u767a\u898b\u3092\u751f\u307f\u51fa\u3057\u3001\u65b0\u305f\u306a\u30d9\u30f3\u30c1\u30e3\u30fc\u4f01\u696d\u3092\u7acb\u3061\u4e0a\u3052\u308b\u5b66\u8853\u6a5f\u95a2\u304b\u3089\u6069\u6075\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5206\u6790<\/p>\n<p>*   \u5317\u7c73: 2024\u5e74\u306e\u53ce\u76ca\u306e41.25%\u3092\u5360\u3081\u3001\u8c4a\u5bcc\u306a\u30d9\u30f3\u30c1\u30e3\u30fc\u8cc7\u91d1\u3001\u4e3b\u8981\u306a\u81e8\u5e8a\u8a66\u9a13\u30a4\u30f3\u30d5\u30e9\u3001\u652f\u63f4\u7684\u306aFDA\u653f\u7b56\u306b\u652f\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u9023\u90a6\u653f\u5e9c\u306e\u30d0\u30a4\u30aa\u30a8\u30b3\u30ce\u30df\u30fc\u30a4\u30cb\u30b7\u30a2\u30c1\u30d6\u306f\u3001\u30b2\u30ce\u30df\u30af\u30b9\u7814\u7a76\u958b\u767a\u3068\u5148\u7aef\u88fd\u9020\u306b\u6570\u5341\u5104\u30c9\u30eb\u306e\u4e88\u7b97\u3092\u5272\u308a\u5f53\u3066\u3001\u56fd\u5185\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30e8\u30fc\u30ed\u30c3\u30d1: \u4e16\u754c\u30af\u30e9\u30b9\u306e\u5b66\u8853\u7814\u7a76\u3068\u3001\u8fb2\u696d\u306e\u5546\u696d\u5316\u3092\u9045\u3089\u305b\u308b\u65ad\u7247\u7684\u306a\u898f\u5236\u304c\u5171\u5b58\u3057\u3066\u3044\u307e\u3059\u3002EU\u306e\u307b\u3068\u3093\u3069\u306e\u907a\u4f1d\u5b50\u7de8\u96c6\u4f5c\u7269\u306b\u5bfe\u3059\u308bGMO\u6307\u5b9a\u306f\u3001\u82f1\u56fd\u3084\u30b9\u30a4\u30b9\u306e\u3088\u308a\u5bdb\u5bb9\u306a\u59ff\u52e2\u3068\u5bfe\u7acb\u3057\u3066\u304a\u308a\u3001\u653f\u7b56\u306e\u8abf\u548c\u304c\u6c42\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b: \u4e2d\u56fd\u306e\u7523\u696d\u653f\u7b56\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u3001\u65e5\u672c\u306e\u30b2\u30ce\u30e0\u7de8\u96c6\u98df\u54c1\u306b\u5bfe\u3059\u308b\u898f\u5236\u5408\u7406\u5316\u3001GDP\u306b80\u5104\u30c9\u30eb\u306e\u8ca2\u732e\u3092\u76ee\u6307\u3059\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306eRNA\u30d6\u30eb\u30fc\u30d7\u30ea\u30f3\u30c8\u306b\u727d\u5f15\u3055\u308c\u300120.23%\u306eCAGR\u3067\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3057\u3066\u3044\u308b\u5730\u57df\u3067\u3059\u3002\u30a4\u30f3\u30c9\u306e\u30ea\u30b9\u30af\u968e\u5c64\u5316\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u306f\u3001\u4f4e\u30ea\u30b9\u30af\u7de8\u96c6\u306e\u8fc5\u901f\u306a\u7d4c\u8def\u3092\u78ba\u7acb\u3057\u3001\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u4f01\u696d\u306e\u8a2d\u7acb\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<\/p>\n<p>\u7af6\u4e89\u5206\u91ce\u306f\u4e2d\u7a0b\u5ea6\u306b\u7d30\u5206\u5316\u3055\u308c\u3066\u3044\u307e\u3059\u3002Thermo Fisher Scientific\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u90e8\u9580\u3092\u6d3b\u7528\u3057\u3066\u3001\u7814\u7a76\u3001\u8a3a\u65ad\u3001\u30d0\u30a4\u30aa\u30d7\u30ed\u30bb\u30b9\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u8a66\u85ac\u3068\u6a5f\u5668\u3092\u4f9b\u7d66\u3057\u3066\u3044\u307e\u3059\u3002Merck KGaA\u306eSigma-Aldrich\u3082\u540c\u69d8\u306e\u30c4\u30fc\u30eb\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u3092\u88dc\u5b8c\u3057\u3001\u6d88\u8017\u54c1\u30b5\u30d6\u30b9\u30af\u30ea\u30d7\u30b7\u30e7\u30f3\u3092\u901a\u3058\u3066\u5f37\u529b\u306a\u9867\u5ba2\u30ed\u30c3\u30af\u30a4\u30f3\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u304c\u5e02\u5834\u306e\u5883\u754c\u3092\u518d\u69cb\u7bc9\u3057\u3066\u3044\u307e\u3059\u3002CRISPR Therapeutics\u306fCASGEVY\u306e\u767a\u58f2\u5f8c\u3001\u53ce\u76ca\u3092\u751f\u307f\u51fa\u3059\u6bb5\u968e\u306b\u79fb\u884c\u3057\u3001\u73fe\u5728\u306f\u5fc3\u8840\u7ba1\u75be\u60a3\u304a\u3088\u3073\u816b\u760d\u8cc7\u7523\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002Intellia Therapeutics\u306fin vivo\u7de8\u96c6\u3092\u512a\u5148\u3057\u300127%\u306e\u4eba\u54e1\u518d\u7de8\u5f8c\u30012027\u5e74\u4ee5\u964d\u3082\u8cc7\u91d1\u304c\u7d99\u7d9a\u3059\u308b\u3068\u898b\u8fbc\u3093\u3067\u3044\u307e\u3059\u3002Regeneron\u3068Mammoth Biosciences\u306e\u63d0\u643a\u306b\u4ee3\u8868\u3055\u308c\u308b\u3088\u3046\u306b\u3001\u63d0\u643a\u6d3b\u52d5\u304c\u6d3b\u767a\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u7279\u8a31\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306f\u4f9d\u7136\u3068\u3057\u3066\u6c7a\u5b9a\u7684\u306a\u8981\u7d20\u3067\u3042\u308a\u3001\u57fa\u790e\u7684\u306aCRISPR IP\u3078\u306e\u30a2\u30af\u30bb\u30b9\u306f\u3001\u65e2\u5b58\u4f01\u696d\u306b\u9632\u5fa1\u7684\u306a\u5800\u3092\u63d0\u4f9b\u3057\u3001\u5c0f\u898f\u6a21\u306a\u53c2\u5165\u4f01\u696d\u306f\u30af\u30ed\u30b9\u30e9\u30a4\u30bb\u30f3\u30b9\u3084\u65b0\u898f\u9175\u7d20\u306e\u767a\u898b\u3092\u901a\u3058\u3066\u3053\u308c\u3092\u4e57\u308a\u8d8a\u3048\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<\/p>\n<p>*   2025\u5e745\u6708: CRISPR Therapeutics\u306fCTX310\u306e\u7b2c1\u76f8\u8a66\u9a13\u3067\u6210\u529f\u3092\u5831\u544a\u3057\u3001\u30c8\u30ea\u30b0\u30ea\u30bb\u30ea\u30c9\u309282%\u3001LDL\u309281%\u524a\u6e1b\u3057\u307e\u3057\u305f\u3002\u73fe\u5728\u300165\u4ee5\u4e0a\u306eCASGEVY\u6cbb\u7642\u30bb\u30f3\u30bf\u30fc\u304c\u7a3c\u50cd\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   2025\u5e745\u6708: Intellia Therapeutics\u306fnexiguran ziclumeran\u306e2\u5e74\u9593\u306e\u30c7\u30fc\u30bf\u767a\u8868\u3067\u300190%\u306eTTR\u30ce\u30c3\u30af\u30c0\u30a6\u30f3\u3068\u795e\u7d4c\u969c\u5bb3\u306e\u6539\u5584\u304c\u6301\u7d9a\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u793a\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2025\u5e745\u6708: \u30df\u30cd\u30bd\u30bf\u5927\u5b66\u306e\u7814\u7a76\u8005\u3089\u306f\u3001CRISPR\u6539\u5909TIL\u7642\u6cd5\u3092\u7528\u3044\u3066\u6d88\u5316\u5668\u304c\u3093\u60a3\u8005\u3067\u5b8c\u5168\u594f\u52b9\u3092\u9054\u6210\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2025\u5e744\u6708: Regeneron\u3068Mammoth Biosciences\u306f\u3001\u591a\u7d44\u7e54\u9001\u9054\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u7126\u70b9\u3092\u5f53\u3066\u305fin vivo CRISPR\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u958b\u59cb\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2025\u5e741\u6708: Intellia Therapeutics\u306fNTLA-2002\u3068nexiguran ziclumeran\u306b\u96c6\u4e2d\u3059\u308b\u305f\u3081\u518d\u7de8\u3092\u884c\u3044\u3001\u4eba\u54e1\u309227%\u524a\u6e1b\u3057\u3001\u8cc7\u91d1\u306e\u7d99\u7d9a\u671f\u9593\u30922027\u5e74\u307e\u3067\u5ef6\u9577\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30b2\u30ce\u30e0\u7de8\u96c6\u5e02\u5834\u306f\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u3001\u533b\u7642\u3001\u8fb2\u696d\u3001\u7523\u696d\u7528\u9014\u306b\u304a\u3044\u3066\u3001\u751f\u4f53\u5185\u306eDNA\u307e\u305f\u306fRNA\u306e\u6a19\u7684\u3068\u306a\u308b\u8ffd\u52a0\u3001\u524a\u9664\u3001\u4fee\u6b63\u3092\u53ef\u80fd\u306b\u3059\u308b\u8a66\u85ac\u3001\u6a5f\u5668\u3001\u30b5\u30fc\u30d3\u30b9\u3001\u304a\u3088\u3073\u30c7\u30ea\u30d0\u30ea\u30fc\u30d9\u30af\u30bf\u30fc\u304b\u3089\u751f\u3058\u308b\u53ce\u76ca\u3068\u5b9a\u7fa9\u3055\u308c\u307e\u3059\u3002\u5f93\u6765\u306e\u30b7\u30fc\u30b1\u30f3\u30b7\u30f3\u30b0\u6d88\u8017\u54c1\u3084\u3001\u7de8\u96c6\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u306b\u76f4\u63a5\u95a2\u9023\u3057\u306a\u3044\u5358\u72ec\u306e\u907a\u4f1d\u5b50\u5408\u6210\u6ce8\u6587\u306f\u3001\u672c\u8abf\u67fb\u306e\u7bc4\u56f2\u304b\u3089\u9664\u5916\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc\uff08\u4e3b\u8981\u306a\u8abf\u67fb\u7d50\u679c\uff09<br \/>\n\u5e02\u5834\u306f\u6025\u901f\u306a\u6210\u9577\u3092\u9042\u3052\u3066\u304a\u308a\u30012025\u5e74\u306b\u306f106\u5104\u7c73\u30c9\u30eb\u306e\u5e02\u5834\u898f\u6a21\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u30022030\u5e74\u307e\u3067\u306b\u306f\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0916.36%\u3067\u6210\u9577\u3057\u3001226.2\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u6280\u8853\u5225\u3067\u306f\u3001CRISPR\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c2024\u5e74\u306b41.62%\u306e\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3001\u5e02\u5834\u3092\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u3001\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u30a4\u30f3\u30c9\u306b\u304a\u3051\u308b\u652f\u63f4\u7684\u306a\u653f\u7b56\u306b\u3088\u308a\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c2030\u5e74\u307e\u3067\u306b20.23%\u306eCAGR\u3067\u6700\u3082\u6025\u901f\u306a\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u907a\u4f1d\u5b50\u7de8\u96c6\u4f5c\u7269\u306e\u56fd\u5883\u3092\u8d8a\u3048\u305f\u898f\u5236\u306e\u65ad\u7247\u5316\u304c\u3001\u4e16\u754c\u5e02\u5834\u3078\u306e\u30a2\u30af\u30bb\u30b9\u306b\u304a\u3051\u308b\u4e3b\u8981\u306a\u8ab2\u984c\u3068\u3057\u3066\u6319\u3052\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u4e3b\u8981\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u63a8\u9032\u3059\u308b\u4f01\u696d\u306b\u306f\u3001CRISPR Therapeutics\u3001Intellia Therapeutics\u3001Mammoth Biosciences\u3001Thermo Fisher Scientific\u3001Merck KGaA\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<br \/>\n\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u4e3b\u306a\u8981\u56e0\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<br \/>\n*   \u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308bCRISPR-Cas\u30b7\u30b9\u30c6\u30e0\u306e\u6025\u901f\u306a\u63a1\u7528<br \/>\n*   \u6c17\u5019\u5909\u52d5\u306b\u5f37\u3044\u4f5c\u7269\u306e\u305f\u3081\u306e\u8fb2\u696d\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u9700\u8981\u306e\u62e1\u5927<br \/>\n*   \u30b2\u30ce\u30e0\u7de8\u96c6\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u4f01\u696d\u3078\u306e\u30d9\u30f3\u30c1\u30e3\u30fc\u30ad\u30e3\u30d4\u30bf\u30eb\u304a\u3088\u3073IPO\u8cc7\u91d1\u8abf\u9054\u306e\u6025\u5897<br \/>\n*   \u5e0c\u5c11\u75be\u60a3\u306b\u5bfe\u3059\u308bin-vivo\u30b2\u30ce\u30e0\u7de8\u96c6\u6cbb\u7642\u6cd5\u306e\u4e3b\u6d41\u5316<br \/>\n*   \u81ea\u52d5\u5316\u304a\u3088\u3073AI\u652f\u63f4\u306b\u3088\u308b\u30cf\u30a4\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u5c0e\u5165<br \/>\n*   \u65b0\u8208\u56fd\u306b\u304a\u3051\u308b\u653f\u5e9c\u306e\u30d0\u30a4\u30aa\u30a8\u30b3\u30ce\u30df\u30fc\u30ed\u30fc\u30c9\u30de\u30c3\u30d7\u306e\u63a8\u9032<\/p>\n<p>\u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<br \/>\n\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u963b\u5bb3\u3059\u308b\u8981\u56e0\u3082\u5b58\u5728\u3057\u307e\u3059\u3002<br \/>\n*   \u30d2\u30c8\u306b\u304a\u3051\u308b\u9577\u671f\u7684\u306a\u30aa\u30d5\u30bf\u30fc\u30b2\u30c3\u30c8\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u306e\u4e0d\u78ba\u5b9f\u6027<br \/>\n*   GMP\u6e96\u62e0\u306e\u30b2\u30ce\u30e0\u7de8\u96c6\u88fd\u9020\u30b9\u30a4\u30fc\u30c8\u306b\u5bfe\u3059\u308b\u9ad8\u984d\u306a\u8a2d\u5099\u6295\u8cc7\uff08CAPEX\uff09<br \/>\n*   \u7de8\u96c6\u3055\u308c\u305f\u7a2e\u5b50\u306b\u95a2\u3059\u308b\u56fd\u5883\u3092\u8d8a\u3048\u305f\u898f\u5236\u306e\u65ad\u7247\u5316<br \/>\n*   \u9ad8\u5ea6\u306a\u5206\u5b50\u751f\u7269\u5b66\u30b9\u30ad\u30eb\u30bb\u30c3\u30c8\u3092\u6301\u3064\u4eba\u6750\u306e\u4e0d\u8db3<\/p>\n<p>\u5e02\u5834\u306e\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<br \/>\n\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u5e02\u5834\u3092\u4ee5\u4e0b\u306e\u4e3b\u8981\u306a\u30bb\u30b0\u30e1\u30f3\u30c8\u306b\u5206\u985e\u3057\u3001\u8a73\u7d30\u306a\u5206\u6790\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6280\u8853\u5225: CRISPR\u3001TALEN\u3001ZFN\u3001Meganucleases\u3001Oligonucleotide-directed Mutagenesis (ODM)\u306a\u3069\u306e\u6280\u8853\u3002<br \/>\n*   \u30c7\u30ea\u30d0\u30ea\u30fc\u65b9\u6cd5\u5225: \u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u3001\u975e\u30a6\u30a4\u30eb\u30b9\u7269\u7406\u7684\u65b9\u6cd5\u3001\u975e\u30a6\u30a4\u30eb\u30b9\u5316\u5b66\u7684\u65b9\u6cd5\u3002<br \/>\n*   \u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u5225: \u7d30\u80de\u682a\u5de5\u5b66\u3001\u907a\u4f1d\u5b50\u30fb\u7d30\u80de\u6cbb\u7642\u3001\u5275\u85ac\u30fb\u6a5f\u80fd\u30b2\u30ce\u30df\u30af\u30b9\u3001\u8fb2\u696d\u4f5c\u7269\u5de5\u5b66\u3001\u8a3a\u65ad\u30fb\u5408\u6210\u751f\u7269\u5b66\u3002<br \/>\n*   \u30a8\u30f3\u30c9\u30e6\u30fc\u30b6\u30fc\u5225: \u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3001\u5b66\u8853\u30fb\u653f\u5e9c\u7814\u7a76\u6a5f\u95a2\u3001\u53d7\u8a17\u7814\u7a76\u6a5f\u95a2\uff08CRO\uff09\u3001\u8fb2\u696d\u30fb\u98df\u54c1\u4f01\u696d\u3002<br \/>\n*   \u5730\u57df\u5225: \u5317\u7c73\u3001\u6b27\u5dde\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u5357\u7c73\u306e\u4e3b\u8981\u5730\u57df\u306b\u7d30\u5206\u5316\u3055\u308c\u3001\u5404\u56fd\u30ec\u30d9\u30eb\u3067\u306e\u5206\u6790\u3082\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<br \/>\n\u7af6\u4e89\u74b0\u5883\u306e\u5206\u6790\u3067\u306f\u3001\u5e02\u5834\u96c6\u4e2d\u5ea6\u3001\u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u3001\u304a\u3088\u3073\u4e3b\u8981\u4f01\u696d\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3055\u308c\u308b\u4f01\u696d\u306b\u306f\u3001Thermo Fisher Scientific Inc.\u3001Merck KGaA\u3001CRISPR Therapeutics AG\u3001Editas Medicine Inc.\u3001Intellia Therapeutics Inc.\u3001Takara Bio Inc.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u8abf\u67fb\u65b9\u6cd5\u8ad6<br \/>\n\u8abf\u67fb\u306f\u3001\u30c4\u30fc\u30eb\u30d9\u30f3\u30c0\u30fc\u3001\u6cbb\u7642\u30b9\u30dd\u30f3\u30b5\u30fc\u3001\u30b3\u30a2\u65bd\u8a2d\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3001\u898f\u5236\u5f53\u5c40\u3068\u306e\u5bfe\u8a71\u3092\u542b\u3080\u4e00\u6b21\u8abf\u67fb\u3068\u3001NIH\u8a66\u9a13\u767b\u9332\u3001FDA\u751f\u7269\u88fd\u5264\u30ea\u30ea\u30fc\u30b9\u3001EUROSTAT\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30c7\u30fc\u30bf\u3001USDA\u30b2\u30ce\u30e0\u7de8\u96c6\u4f5c\u7269\u63a1\u7528\u8abf\u67fb\u3001ClinicalTrials.gov\u7d71\u8a08\u3001WIPO\u7279\u8a31\u51fa\u9858\u306a\u3069\u306e\u4e8c\u6b21\u8abf\u67fb\u3092\u7d44\u307f\u5408\u308f\u305b\u3066\u5b9f\u65bd\u3055\u308c\u307e\u3057\u305f\u3002\u5e02\u5834\u898f\u6a21\u306e\u7b97\u51fa\u3068\u4e88\u6e2c\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306aR&#038;D\u304a\u3088\u3073\u81e8\u5e8a\u652f\u51fa\u3001\u30b2\u30ce\u30e0\u7de8\u96c6\u4f5c\u7269\u306e\u4f5c\u4ed8\u9762\u7a4d\u3001GMP\u30d9\u30af\u30bf\u30fc\u751f\u7523\u91cf\u304b\u3089\u59cb\u307e\u308b\u30c8\u30c3\u30d7\u30c0\u30a6\u30f3\u30e2\u30c7\u30eb\u3092\u69cb\u7bc9\u3057\u3001\u30b5\u30d7\u30e9\u30a4\u30e4\u30fc\u306e\u8acb\u6c42\u66f8\u3084\u30c1\u30e3\u30cd\u30eb\u30c1\u30a7\u30c3\u30af\u3067\u691c\u8a3c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30c7\u30fc\u30bf\u306f\u6bce\u5e74\u66f4\u65b0\u3055\u308c\u3001\u91cd\u8981\u306a\u30a4\u30d9\u30f3\u30c8\u5f8c\u306b\u306f\u4e2d\u9593\u66f4\u65b0\u304c\u884c\u308f\u308c\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u5c55\u671b<br \/>\n\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u5e02\u5834\u306e\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u5c55\u671b\u306b\u3064\u3044\u3066\u3082\u8a00\u53ca\u3055\u308c\u3066\u304a\u308a\u3001\u672a\u958b\u62d3\u306e\u9818\u57df\u3084\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u306e\u8a55\u4fa1\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/94150"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=94150"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/94150\/revisions"}],"predecessor-version":[{"id":94153,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/94150\/revisions\/94153"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=94150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=94150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=94150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}